I. Garagiola

发表

Immune Responses to Plasma-Derived Versus Recombinant FVIII Products

F. Peyvandi, S. Miri, I. Garagiola, 2021, Frontiers in Immunology.

Product type and other environmental risk factors for inhibitor development in severe hemophilia A

F. Peyvandi, I. Garagiola, 2018, Research and practice in thrombosis and haemostasis.

A Randomized Trial of Factor VIII and Neutralizing Antibodies in Hemophilia A.

V. Ramanan, P. Mannucci, F. Rosendaal, 2016, The New England journal of medicine.

Factor VIII products in haemophilia A: one size fits all?

P. Mannucci, I. Garagiola, 2015, Thrombosis and haemostasis.

Source and purity of factor VIII products as risk factors for inhibitor development in patients with hemophilia A

P. Mannucci, E. Santagostino, P. Mannucci, 2012, Journal of thrombosis and haemostasis : JTH.

State of the art on clinical trials of gene therapy in haemophilia

F. Peyvandi, I. Garagiola, 2020 .

Role of von Willebrand factor in the haemostasis.

F. Peyvandi, I. Garagiola, L. Baronciani, 2011, Blood transfusion = Trasfusione del sangue.

Severe hemophilia with mild bleeding phenotype: molecular characterization and global coagulation profile

M. Clerici, P. Mannucci, E. Santagostino, 2010, Journal of thrombosis and haemostasis : JTH.

Performance of a clinical risk prediction model for inhibitor formation in severe haemophilia A

V. Ramanan, F. Rosendaal, P. Mannucci, 2021, Haemophilia.

The EHA Research Roadmap: Blood Coagulation and Hemostatic Disorders

T. van der Poll, D. Trégouët, P. Morange, 2021, HemaSphere.

ADAMTS13 mutations and polymorphisms in congenital thrombotic thrombocytopenic purpura

F. Peyvandi, I. Garagiola, R. Palla, 2010, Human mutation.

Pregnancy complications and obstetric care in women with inherited bleeding disorders

A. Federici, F. Peyvandi, I. Garagiola, 2013, Haemophilia : the official journal of the World Federation of Hemophilia.

Real‐life experience in switching to new extended half‐life products at European haemophilia centres

C. Hermans, M. Makris, F. Peyvandi, 2019, Haemophilia : the official journal of the World Federation of Hemophilia.

A rare inherited coagulation disorder: Combined homozygous factor VII and factor X deficiency

P. Mannucci, F. Peyvandi, I. Garagiola, 2004, American journal of hematology.

Characterization of four microsatellites in an Italian population and their application to paternity testing.

G. Colucci, I. Garagiola, S. Sirchia, 1996, Molecular and cellular probes.

Nonsense-mediated mRNA decay in the ADAMTS13 gene caused by a 29-nucleotide deletion

F. Peyvandi, I. Garagiola, C. Valsecchi, 2008, Haematologica.

Treatment of Hemophilia in the Near Future

F. Peyvandi, I. Garagiola, 2015, Seminars in Thrombosis & Hemostasis.

Advances in the treatment of bleeding disorders

F. Peyvandi, I. Garagiola, E. Biguzzi, 2016, Journal of thrombosis and haemostasis : JTH.

The first deletion mutation in the TSP1-6 repeat domain of ADAMTS13 in a family with inherited thrombotic thrombocytopenic purpura

R. De Cristofaro, F. Peyvandi, I. Garagiola, 2009, Haematologica.

Clustered F8 missense mutations cause hemophilia A by combined alteration of splicing and protein biosynthesis and activity

F. Bernardi, M. Pinotti, A. Branchini, 2017, Haematologica.

Degradation of two novel congenital TTP ADAMTS13 mutants by the cell proteasome prevents ADAMTS13 secretion.

F. Peyvandi, I. Garagiola, I. Mackie, 2016, Thrombosis research.

Title : Degradation of two novel congenital TTP ADAMTS 13 mutants by the cell proteasome prevents ADAMTS 13 secretion

Mackie, F. Peyvandi, I. Garagiola, 2016 .

Pitfalls in molecular diagnosis in a family with severe factor VII (FVII) deficiency—misdiagnosis by direct sequence analysis using a PCR product

F. Peyvandi, I. Garagiola, R. Palla, 2003, Prenatal diagnosis.

Identification of 217 unreported mutations in the F8 gene in a group of 1,410 unselected Italian patients with hemophilia A

M. Margaglione, E. Grandone, A. Lombardi, 2008, Journal of Human Genetics.

Long‐term prophylaxis in severe factor VII deficiency

F. Peyvandi, I. Garagiola, E. Biguzzi, 2015, Haemophilia : the official journal of the World Federation of Hemophilia.

Residual plasmatic activity of ADAMTS13 is correlated with phenotype severity in congenital thrombotic thrombocytopenic purpura.

R. Gibbs, G. Remuzzi, M. Noris, 2012, Blood.

A novel CD46 mutation in a patient with microangiopathy clinically resembling thrombotic thrombocytopenic purpura and normal ADAMTS13 activity

G. Ardissino, F. Peyvandi, I. Garagiola, 2015, Haematologica.

Management of pregnancy and delivery in women with inherited bleeding disorders.

F. Peyvandi, I. Garagiola, C. Bidlingmaier, 2011, Seminars in fetal & neonatal medicine.

Genotyp-Phenotype Correlation in Congenital ADAMTS13 Deficient Patients

R. Klaassen, F. Peyvandi, I. Garagiola, 2008 .

Detection of maternal DNA in human cord blood stored for allotransplantation by a highly sensitive chemiluminescent method.

G. Sirchia, I. Garagiola, S. Sirchia, 1997, Journal of hematotherapy.

The past and future of haemophilia: diagnosis, treatments, and its complications

Flora Peyvandi, Guy Young, F. Peyvandi, 2016, The Lancet.

Genetic diagnosis of haemophilia and other inherited bleeding disorders

P. Mannucci, M. Chandy, S. Duga, 2006, Haemophilia : the official journal of the World Federation of Hemophilia.

Risk factors for inhibitor development in severe hemophilia a.

F. Peyvandi, I. Garagiola, R. Palla, 2018, Thrombosis research.

Source of Factor VIII Replacement (PLASMATIC OR RECOMBINANT) and Incidence of Inhibitory Alloantibodies in Previously Untreated Patients with Severe Hemophilia a: The Multicenter Randomized Sippet Study

Miguel Ángel Martínez, P. Mannucci, E. Santagostino, 2015 .

Future of coagulation factor replacement therapy

F. Peyvandi, I. Garagiola, S. Seregni, 2013, Journal of thrombosis and haemostasis : JTH.

Whole-exome sequencing to identify genetic risk variants underlying inhibitor development in severe hemophilia A patients.

Flora Peyvandi, Kevin Blighe, E. Santagostino, 2016, Blood.

Gynecological and obstetrical manifestations of inherited bleeding disorders in women

F. Peyvandi, I. Garagiola, M. Menegatti, 2011, Journal of thrombosis and haemostasis : JTH.

Timing and severity of inhibitor development in recombinant versus plasma‐derived factor VIII concentrates: a SIPPET analysis

F. Rosendaal, P. Mannucci, F. Peyvandi, 2018, Journal of thrombosis and haemostasis : JTH.

Prediction of factor VIII inhibitor development in the SIPPET cohort by mutational analysis and factor VIII antigen measurement

F. Rosendaal, P. Mannucci, F. Peyvandi, 2018, Journal of thrombosis and haemostasis : JTH.

Genetic risk stratification to reduce inhibitor development in the early treatment of hemophilia A: a SIPPET analysis.

F. Rosendaal, P. Mannucci, F. Peyvandi, 2017, Blood.

Updates on Novel Non-Replacement Drugs for Hemophilia

A. Ciavarella, S. Pasca, F. Peyvandi, 2022, Pharmaceuticals.

Nonneutralizing antibodies against factor VIII and risk of inhibitor development in severe hemophilia A.

F. Rosendaal, P. Mannucci, F. Peyvandi, 2017, Blood.

Clinical advances in gene therapy updates on clinical trials of gene therapy in haemophilia

F. Peyvandi, I. Garagiola, 2019, Haemophilia : the official journal of the World Federation of Hemophilia.

Prenatal diagnosis and preimplantation genetic diagnosis: novel technologies and state of the art of PGD in different regions of the world

F. Peyvandi, I. Garagiola, M. Mortarino, 2011, Haemophilia : the official journal of the World Federation of Hemophilia.

Prenatal diagnosis of haemophilia B: the Italian experience

M. Bicocchi, I. Garagiola, A. Rocino, 2013, Haemophilia : the official journal of the World Federation of Hemophilia.

Development of a Specific Monoclonal Antibody to Detect Male Cells Expressing the RPS4Y1 Protein

C. Cordiglieri, F. Peyvandi, I. Garagiola, 2021, International journal of molecular sciences.

Mutations in the MCFD2 gene and a novel mutation in the LMAN1 gene in Indian families with combined deficiency of factor V and VIII

D. Mohanty, K. Ghosh, F. Peyvandi, 2005, American journal of hematology.

Molecular Aggregation of Marketed Recombinant FVIII Products: Biochemical Evidence and Functional Effects

R. De Cristofaro, F. Peyvandi, I. Garagiola, 2019, TH Open.

Post-authorization pharmacovigilance for hemophilia in Europe and the USA: Independence and transparency are keys.

P. Mannucci, F. Peyvandi, I. Garagiola, 2021, Blood reviews.

Role of the 2 adenine (g.11293_11294insAA) insertion polymorphism in the 3′ untranslated region of the factor VII (FVII) gene: molecular characterization of a patient with severe FVII deficiency

P. Mannucci, N. Marziliano, F. Peyvandi, 2005, Human mutation.

Losses of heterozygosity in endometrial adenocarcinomas: positive correlations with histopathological parameters.

G. Pardi, S. Garsia, I. Garagiola, 2000, Cancer genetics and cytogenetics.

Losses of heterozygosity in oral and oropharyngeal epithelial carcinomas.

R. Brusati, A. Bozzetti, I. Garagiola, 2000, Cancer genetics and cytogenetics.

Cytogenetic abnormalities and microsatellite instability in endometrial adenocarcinoma.

I. Garagiola, G. Simoni, S. Sirchia, 1997, Cancer genetics and cytogenetics.

Trisomic zygote rescue revealed by DNA polymorphism analysis in confined placental mosaicism

G. Colucci, F. Lalatta, I. Garagiola, 1998, Prenatal diagnosis.

Highly sensitive chemiluminescent method for the detection of maternal cell contamination in human cord blood stored for allotransplantation: the experience of the Milano cord blood bank.

G. Sirchia, I. Garagiola, S. Sirchia, 1997, Blood.

X Chromosome inactivation: a modifier of factor VIII and IX plasma levels and bleeding phenotype in Haemophilia carriers

E. Santagostino, F. Peyvandi, I. Garagiola, 2020, European Journal of Human Genetics.

Genetic variants at the chromosomal region 2q21.3 underlying inhibitor development in patients with severe haemophilia A

F. Peyvandi, I. Garagiola, S. Hassan, 2022, Haemophilia : the official journal of the World Federation of Hemophilia.

Detection of maternal DNA in cord blood at birth after elective caesarean section or vaginal delivery.

M. Newell, I. Garagiola, G. Simoni, 2000, AIDS (London).

Highly sensitive chemiluminescent method for the detection of cell contamination.

I. Garagiola, G. Simoni, F. Grati, 1998, Journal of bioluminescence and chemiluminescence.

Absence of detectable maternal DNA and identification of proviral HIV in the cord blood of two infants who became HIV-infected.

G. Pardi, I. Garagiola, G. Simoni, 1997, AIDS.

The P303T mutation in the human factor VII (FVII) gene alters the conformational state of the enzyme and causes a severe functional deficiency

P. Mannucci, F. Peyvandi, I. Garagiola, 2004, British journal of haematology.

Fitusiran in haemophilia: a breakthrough drug with many unknowns

F. Peyvandi, I. Garagiola, M. Abbattista, 2023, The Lancet.

Reproductive care in human immunodeficiency virus serodiscordant couples with haemophilia.

F. Peyvandi, I. Garagiola, M. Mortarino, 2013, Blood transfusion = Trasfusione del sangue.

The Experience of the Milano Cord Blood Bank Cell Contamination in Human Cord Blood Stored for Allotransplantation: Highly Sensitive Chemiluminescent Method for the Detection of Maternal

G. Sirchia, I. Garagiola, L. Crespiatico, 2012 .

Genetic Variants Identified by Whole Exome Sequencing in a Large Italian Family with High Plasma Levels of Factor VIII and Von Willebrand Factor

F. Peyvandi, I. Garagiola, S. Spena, 2023, International journal of molecular sciences.

MOLECULAR STUDY OF VASCULAR ENDOTHELIAL GROWTH FACTOR GENE IN IRANIAN PATIENTS AFTER MYOCARDIAL INFARCTION

F. Peyvandi, I. Garagiola, M. Karimi, 2006 .

Factor VIII products in haemophilia A: one size fits all?

I. Garagiola, P. Mannuccio Mannucci, 2015, Thrombosis and Haemostasis.

Psychological and cognitive factors involved in decision‐making process of haemophilia carriers in reproductive choices

G. Pravettoni, F. Peyvandi, I. Garagiola, 2023, Haemophilia : the official journal of the World Federation of Hemophilia.

Gender equity in hemophilia: need for healthcare, familial, and societal advocacy

I. Garagiola, S. Spena, M. Mortarino, 2024, Frontiers in medicine.